According to the American Medical Association, 10 percent of Americans are allergic to penicillin. However, researchers at the Mayo Clinic said that that number could be closer to 1 percent.
For the study, UW-Eau Claire electronic health records were used to contact students listed with penicillin allergies.
Students who participated in the study were given a low dose of amoxicillin and monitored for allergic reactions. So far, of the 61 participants in the study, only one participant was truly allergic to penicillin and amoxicillin, according to the Leader-Telegram.
“If a patient does carry a penicillin allergy later into life, it is associated with a higher morbidity and mortality because they’re more likely to be exposed to other antibiotics that have safety concerns or don’t work as well,” said Kim Frodl, MD, medical director of student health services at UW-Eau Claire. “If we can free up that class of antibiotics, it would potentially make a big difference for their overall health.”
The study is expected to continue in the fall.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
